
Source: ©Freudenberg Performance Materials
Foshan United Medical, headquartered in Foshan, China, employs about 200 people. The purchase price was not disclosed. The sellers were UMT founder and CEO Dr. Xiaodong Wang and a private Chinese founding partner.
“Freudenberg Performance Materials and Foshan United Medical are a perfect strategic match,” said Dr. Andreas Raps, CEO of Freudenberg Performance Materials. “Going forward, the merger will enable us to offer a unique portfolio of technologies and products as an innovative full-service supplier in the market for advanced wound care.”
UMT’s capabilities span fiber manufacturing and functionalization, nonwoven production, final packaging, sterilization and marketing authorization. Its portfolio includes polyurethane foam dressings, silicone-coated dressings, antimicrobial dressings containing silver, alginate-based absorbent fibers, and chitosan- and CMC-based wound dressings.
“The innovative strength and high level of customer-orientation characteristics in both our companies make for an ideal fit,” Wang said.
2026 Quarterly Issue III


